Insmed Incorporated · 1 week ago
Senior Director, Commercial Forecasting and Competitive Intelligence
Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. The Senior Director, Commercial Forecasting and Competitive Intelligence will lead efforts to analyze the competitive landscape and provide strategic forecasts across Insmed’s pipeline and in-market products, partnering closely with cross-functional stakeholders to optimize commercial opportunities.
BiotechnologyMedicalPharmaceutical
Responsibilities
Lead the development of robust demand forecasts for both in-market and pipeline products, considering clinical development milestones, market access assumptions, and competitive landscapes
Develop scenario-based models to account for various potential market conditions, competitive actions, and regulatory changes
Provide / guide ongoing updates and adjustments to forecasts based on emerging data and market developments
Prepare detailed reports and conduct clear presentations for senior leadership, summarizing market dynamics and forecast adjustments
Lead the monitoring and synthesis of competitive data (e.g., clinical trial databases, market research, scientific publications) to provide actionable insights for senior leadership and cross-functional teams
Communicate complex market and competitive intelligence findings in a clear, concise manner to both technical and non-technical audiences
Work closely with Commercial teams to provide insights that support strategic decision-making, including portfolio management and market entry planning
Collaborate with Clinical, Regulatory, and Commercial teams to ensure that forecast assumptions are aligned with clinical trial plans, development milestones, market launch plans, and commercial strategy
Partner with Finance and Investor Relations to ensure that competitive intelligence and forecast data are integrated into corporate financial projections and external communications
Qualification
Required
Bachelor's degree in business, finance, engineering or related discipline required
8+ years of leadership experience in developing product forecasts and market assessments within the biotech or pharmaceutical industry
Extensive knowledge of pharmaceutical data (e.g., sales, specialty pharmacy, payer, longitudinal patient-level data)
Experience with advanced analytical modeling; experience with secondary data [e.g., APLD medical claims data, audited TRx data (IQVIA or Symphony Health), and epidemiology references]
Strong blend of technical proficiency, business acumen, and experience informing business growth and opportunity
Collaborative and influential leadership style, with the ability to build strong partnerships across the organization
High proficiency in MS Office (Excel/PowerPoint)
Agile team player; able to adapt and execute based on evolving business needs, with strong active listening skills
Ability to extract and quickly process key information, summarize needs of cross-functional teams, and provide targeted and appropriate insights and recommendations
Skilled at leading without authority in a cross-functional environment
Preferred
Advanced degree preferred
Benefits
Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back
Company
Insmed Incorporated
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-13
2026-01-11
Company data provided by crunchbase